收藏切换
Effect analysis of levothyroxine replacement therapy in postmenopausal patients with subclinical hypothyroidism
收藏切换
Xingqiang CHEN1, Guoliang ZENG2, *, Shaolian CAI1
World Clinical Drug | 2024, 45(10) : 1053 - 1057
Less
收藏切换
World Clinical Drug | 2024, 45(10): 1053-1057
• Article •
Effect analysis of levothyroxine replacement therapy in postmenopausal patients with subclinical hypothyroidism
Full
Xingqiang CHEN1, Guoliang ZENG2, *, Shaolian CAI1
Affiliations
  • 1.Zhaoqing Medical College, Zhaoqing 526020, Guangdong Province, China
  • 2.Department of Internal Medicine, the First People's Hospital of Zhaoqing, Zhaoqing 526000, Guangdong Province, China
Published: 2024-10-10 doi: 10.13683/j.wph.2024.10.009
Outline
收藏切换
Objective

To investigate the effects of levothyroxine replacement therapy on subclinical hypothyroidism (SCH) after menopause.

Methods

A total of 90 postmenopausal SCH patients diagnosed in the First People's Hospital of Zhaoqing from January 2020 to June 2022 were selected as research objects and divided into control group and study group according to simple sort randomization method, with 45 cases in each group. The control group received conventional symptomatic treatment, and the study group received levothyroxine replacement treatment. The clinical effective rate, thyroid function, blood lipid level and the occurrence of adverse reactions were compared between the two groups.

Results

After treatment, the total effective rate of the study group was higher than that of the control group (95.56% vs 80.00%, P<0.05). After treatment, there were no significant differences between the two groups in the levels of free triiodothyronine, serum free thyroxine and anti-thyroid peroxidase antibody (P>0.05), but the level of thyroid stimulating hormone (TSH) in the study group was higher than that in the control group (P<0.05). The levels of total cholesterol, triglyceride and low density lipoprotein cholesterol in the study group were lower than those in the control group (P<0.05), and the level of high density lipoprotein cholesterol was higher than that in the control group (P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups (P>0.05).

Conclusion

Levothyroxine replacement therapy is an effective and feasible medication regimen for postmenopausal SCH patients, which can help control TSH level, regulate blood lipid, and has good drug safety.

levothyroxine  /  alternative therapy  /  menopause  /  subclinical hypothyroidism
陈兴强, 曾国良, 蔡少莲. 左甲状腺素替代治疗对绝经后亚临床甲状腺功能减退症患者的效果分析. 世界临床药物, 2024 , 45 (10) : 1053 -1057 . DOI: 10.13683/j.wph.2024.10.009
Xingqiang CHEN, Guoliang ZENG, Shaolian CAI. Effect analysis of levothyroxine replacement therapy in postmenopausal patients with subclinical hypothyroidism[J]. World Clinical Drug, 2024 , 45 (10) : 1053 -1057 . DOI: 10.13683/j.wph.2024.10.009
Year 2024 volume 45 Issue 10
14
3
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2024.10.009
  • Receive Date:2024-06-28
  • Online Date:2026-11-17
  • Published:2024-10-10
Article Data
Affiliations
History
  • Received:2024-06-28
  • Revised:2024-09-02
Affiliations
    1.Zhaoqing Medical College, Zhaoqing 526020, Guangdong Province, China
    2.Department of Internal Medicine, the First People's Hospital of Zhaoqing, Zhaoqing 526000, Guangdong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.10.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT